[Total joints edition] Biologics decreases total joint replacements in patients with rheumatoid arthritis | Chinese billionaire ups stake in CHS as stock tumbles | Stryker, Zimmer Biomet, DePuy Synthes & more: 12 device company notes | Hip arthroscopies are up – Who is performing them? 5 key notes


From: Becker's Orthopedic Review <scott@beckersasc.com>
Subject: [Total joints edition] Biologics decreases total joint replacements in patients with rheumatoid arthritis | Chinese billionaire ups stake in CHS as stock tumbles | Stryker, Zimmer Biomet, DePuy Synthes & more: 12 device company notes | Hip arthroscopies are up - Who is performing them? 5 key notes
Preheader:
Reply: scott@beckersasc.com


 
           

Dec. 27, 2017

TODAY'S TOP STORIES


1. Biologics decreases total joint replacements in patients with rheumatoid arthritis Full story  

2. Chinese billionaire ups stake in CHS as stock tumbles 


3. Stryker, Zimmer Biomet, DePuy Synthes & more: 12 device company notes 

4. Webinar: Impacts and Insights from Investing in Patient Financial Care. 

5. Hip arthroscopies are up - Who is performing them? 5 key notes 

 

6. Orthopedic surgeon leader to know: Dr. Christopher Baker of Florida Orthopaedic Institute Full story

                                                                       

    

                                                                                              

               
                
Channels


Channels

Editorial Contact:
Laura Dyrda
Editor-in-chief
(800) 417-2035

Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Healthcare, 17 N. State St., #1800, Chicago, IL 60601
Sent by scott@beckersasc.com in collaboration with
Constant Contact